Paper Details

  1. Home
  2. Paper Details

Pentoxifylline in the treatment of neonatal vasospasm and thromboembolism: An observational case series study.

Author: BayraktarSüleyman, Tanyeri-BayraktarBilge

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

This case series describes the successful and safe use of PTX for the treatment of vasospasm and thrombosis in neonates.
Paper Details　
Original Abstract of the Article :
Newborns, particularly preterm babies, are prone to vascular vasospasm and thromboembolism. Differences in the haemostatic system, small vessel diameter and presence of any serious diseases are predisposing causes of thromboembolic disease in newborns. The lack of randomized controlled studies on th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jcpt.13565

データ提供：米国国立医学図書館（NLM）

Pentoxifylline: A Potential Lifesaver for Neonatal Vasospasm and Thromboembolism

This study examines the potential of pentoxifylline (PTX) in treating neonatal vasospasm and thromboembolism, common complications that can arise in newborns, particularly preterm babies. Researchers present a case series demonstrating the safe and effective use of PTX in managing these conditions, providing valuable insights into its potential therapeutic role.

Pentoxifylline: A Ray of Hope for Fragile Newborns

This study highlights the potential of PTX as a treatment option for neonatal vasospasm and thromboembolism. Imagine a delicate desert flower struggling to survive in harsh conditions. That's the fragility of newborns, and PTX could be a vital lifeline. This research sheds light on the potential of PTX to help manage these conditions, offering hope for a better outcome for newborns facing these challenges.

Pentoxifylline: A Promising Approach for Neonatal Health

This study provides valuable data on the use of PTX in managing neonatal vasospasm and thromboembolism. While further research is needed, this research offers a promising direction for improving the care of vulnerable newborns. It emphasizes the importance of continued exploration into safe and effective treatments for conditions that can significantly impact the health and well-being of newborns.

Dr.Camel's Conclusion

This research provides a compelling case for exploring the therapeutic potential of PTX in treating neonatal vasospasm and thromboembolism. Like a camel navigating a treacherous desert landscape, PTX could offer a crucial aid in navigating the complexities of neonatal health. This research serves as a reminder that even in the most challenging situations, there's always hope for finding solutions.
Date :
  1. Date Completed 2022-04-20
  2. Date Revised 2022-04-20
Further Info :

Pubmed ID

34726284

DOI: Digital Object Identifier

10.1111/jcpt.13565

Related Literature

Article Analysis
・Side Effects of pentoxifylline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.